Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: United Kingdom Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20063
20071
20086
20095
20104
20114
20123
20135
20142
20151
20166
20174
20187
20196
20203
202112
20224
20238
20243
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated25
Recruiting10
Active, not recruiting6
Unknown status5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion17
Novartis Pharmaceuticals10
United Therapeutics8
Bial - Portela C S.A.5
Merck Sharp & Dohme LLC5
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA4
Imperial College London4
Bayer3
Aerovate Therapeutics2
Biogen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension98
Hypertension, Pulmonary34
Hypertension7
Familial Primary Pulmonary Hypertension6
Cardiovascular Diseases5
Connective Tissue Diseases4
Lung Diseases4
Vascular Diseases4
Heart Failure3
Anxiety Disorders2

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.